Ivanka Hendrix
Overview
Explore the profile of Ivanka Hendrix including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
651
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smyth J, Umapathysivam K, Hendrix I, Grantham H, Arendts G, Visvanathan R
Emerg Med Australas
. 2022 Aug;
34(5):675-686.
PMID: 35987952
Residents from residential aged care services (RACS) (i.e. nursing homes) many of whom are frail or disabled, are frequently transferred to ED for treatment of acute episodes of illness or...
2.
Hendrix I, Page A, Korhonen M, Bell J, Tan E, Visvanathan R, et al.
Drugs Real World Outcomes
. 2019 Jul;
6(3):105-113.
PMID: 31264165
Aim: While proton pump inhibitors (PPIs) are generally considered safe and well tolerated, frail older people who take PPIs long term may be susceptible to adverse events. This study characterized...
3.
Russell P, Laubscher S, Roberts G, Mangoni A, McDonald C, Hendrix I, et al.
Ther Adv Drug Saf
. 2019 Jun;
10:2042098619854876.
PMID: 31210924
Background: Patients from residential aged care facilities are commonly exposed to inappropriate polypharmacy. Unplanned inpatient admissions can provide an opportunity for review of complex medical regimens and deprescribing of inappropriate...
4.
Sluggett J, Hendrix I, Bell J
Res Social Adm Pharm
. 2017 Apr;
14(2):124-126.
PMID: 28424148
No abstract available.
5.
Wilsdon T, Hendrix I, Thynne T, Mangoni A
Drugs Aging
. 2017 Feb;
34(4):265-287.
PMID: 28220380
Background: The use of proton pump inhibitors (PPIs) in older adults is high, often inappropriate, and may cause harm. Deprescribing is defined as the reduction, withdrawal, or discontinuation of inappropriate...
6.
Reeve E, Andrews J, Wiese M, Hendrix I, Roberts M, Shakib S
Ann Pharmacother
. 2014 Nov;
49(1):29-38.
PMID: 25385826
Background: Proton pump inhibitors (PPIs) are inappropriately prescribed in up to 50% of users. Systematic medication review and cessation of inappropriate medications or deprescribing may improve patient outcomes and reduce...
7.
Reeve E, Shakib S, Hendrix I, Roberts M, Wiese M
Med J Aust
. 2014 Oct;
201(7):386-9.
PMID: 25296058
Deprescribing is the process of trial withdrawal of inappropriate medications. Currently, the strongest evidence for benefit of deprescribing is from cohort and observational studies of withdrawal of specific medication classes...
8.
Reeve E, Shakib S, Hendrix I, Roberts M, Wiese M
Br J Clin Pharmacol
. 2014 Mar;
78(4):738-47.
PMID: 24661192
Inappropriate use of medication is widespread, especially in older people, and is associated with risks, including adverse drug reactions, hospitalization and increased mortality. Optimization of appropriate medication use to minimize...
9.
Reeve E, Wiese M, Hendrix I, Roberts M, Shakib S
J Am Geriatr Soc
. 2013 Sep;
61(9):1508-14.
PMID: 24028356
Objectives: To capture people's attitudes, beliefs, and experiences regarding the number of medications they are taking and their feelings about stopping medications. Design: Administration of a validated questionnaire. Setting: Multidisciplinary...
10.
Reeve E, To J, Hendrix I, Shakib S, Roberts M, Wiese M
Drugs Aging
. 2013 Aug;
30(10):793-807.
PMID: 23912674
Background: Inappropriate medication use is common in the elderly and the risks associated with their use are well known. The term deprescribing has been utilised to describe the complex process...